The PE Ratio as of November 2025 (TTM) for Gene Biotherapeutics, Inc. (CRXM) is -0.01

According to Gene Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -99.59% compared to the average of -1.22 of the last 4 quarters.

Gene Biotherapeutics, Inc. (CRXM) Historical PE Ratio (quarterly & annually)

How has CRXM PE Ratio performed in the past?

The mean historical PE Ratio of Gene Biotherapeutics, Inc. over the last ten years is -1.02. The current -0.01 PE Ratio has changed -50.79% with respect to the historical average. Over the past ten years (40 quarters), CRXM's PE Ratio was at its highest in in the September 2018 quarter at 0.71. The PE Ratio was at its lowest in in the March 2011 quarter at -4.73.

Gene Biotherapeutics, Inc. (CRXM) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Gene Biotherapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Gene Biotherapeutics, Inc. (CRXM) Average PE Ratio

How has CRXM PE Ratio performed in the past?

The current PE Ratio of Gene Biotherapeutics, Inc. (CRXM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Gene Biotherapeutics, Inc. (CRXM) PE Ratio vs. Peers

How is CRXM’s PE Ratio compared to its peers?

Gene Biotherapeutics, Inc.’s PE Ratio is greater than Gelesis Holdings, Inc. (-0.20), less than NeonMind Biosciences Inc. (0), greater than E-Qure Corp. (-0.01), less than GeneThera, Inc. (-0.00), less than American CryoStem Corporation (-0.00), greater than Capha Pharmaceuticals Inc. (-0.16), less than Acacia Diversified Holdings, Inc. (-0.00), less than Generex Biotechnology Corporation (-0.00), less than Navidea Biopharmaceuticals, Inc. (-0.00), less than WPD Pharmaceuticals Inc. (283.88),

Build a custom stock screener for Gene Biotherapeutics, Inc. (CRXM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gene Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gene Biotherapeutics, Inc. (CRXM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gene Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.